【原美源伯根】Cencora (COR) 2013年年度报告「NYSE」.pdf

《【原美源伯根】Cencora (COR) 2013年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《【原美源伯根】Cencora (COR) 2013年年度报告「NYSE」.pdf（24页珍藏版）》请在三个皮匠报告上搜索。

1、2013 Summary Annual ReportDelivering GrowthDeliveringGrowthTo Our Stockholders:I am very pleased to report that in our fiscal year 2013,AmerisourceBergen not only performed well operationally and financially,but we also took groundbreaking steps to strengthenthe strategic position of our core busine

2、ss andcontinued to lay the groundwork for meaningfulinternational expansion.Since our formation in 2001,AmerisourceBergen has demonstrated a strong commitment to excellent operational execution and disciplined capital management.In the last few years we have made substantial investments and establis

3、hed new customer relationships that enhance our ability to deliver growth while remaining focused on the pharmaceutical supply chain.CONTENTS 1 Letter to Stockholders,Steven H.Collis,President and Chief Executive Officer 4 Global Pharmaceutical Sourcing and Distribution 6 Pharmacy Solutions 8 Provid

4、er Solutions 10 Manufacturer Solutions 12 Corporate and Social Responsibility 14 Management Team 15 Letter to Stockholders,Richard C.Gozon,Chairman of the Board 16 Financial Statements 21 Corporate InformationSteven h.Collis,President and Chief Executive OfficerWhile the u.S.pharmaceutical market is

5、 improving as a result of aging demographics,an expansion ofhealthcare coverage as a result of theAffordable Care Act,and new productlaunches,there are even greateropportunities for global growth.ImShealth is forecasting that the u.S.market will grow approximately 2.3%annually from 2013 through 2017

6、,but global spending on medicines willincrease 24%over the same period.Our increasing focus on global sourcingand distribution services that improveproduct access,increase supply chainefficiency,and enhance patient care,position us well to seize theseopportunities for growth.Fiscal 2013A Transformat